Studies have also shown that berberine can reduce the expression of programmed cell death 1 ligand 1 (PD‐L1) by inhibiting the deubiquitination activity of COP9 signalosome subunit 5 in nonsmall cell lung cancer, thereby promoting antitumor immunity [134]. This evidence concerns the gene CD274 and lung cancer.